People

Direktlink :
Contents; Accesskey: 2 | Hauptnavigation; Accesskey: 3 | Servicenavigation; Accesskey: 4

People

Results: 64
  • ...
To produce his valuable fine chemicals, Falk Harnisch electrifies the inhabitants of muddy dwellings. He calls this microbial ‘bioelectrotechnology’. 11.01.2013

Falk Harnisch: The electrified biotechnologist

The biochemist Falk Harnisch has made it his mission to produce industrial chemicals using current-carrying bacteria. Aided by a BMBF Research Award, he is building up his own working group in Leipzig.

At the Hannover Medical School, Reinhold Förster is studying how immune cells migrate to the lymph nodes. 31.12.2012

Reinhold Förster: Tracker of the immune system

Reinhold Förster is studying the migration movements of immune cells using the latest techniques in microscopy. The European Research Council ERC is funding his research into cellular activity in the lymph nodes with a seven-figure-euro sum.

Thorsten Eggert, habilitated microbiologist and founder of Evocatal. 23.11.2012

Thorsten Eggert: The enzyme optimiser

“Just doing research” was not enough for the successful microbiologist. Finding no industrial partner for his optimised enzymes, he took matters into his own hands and founded the Düsseldorf-based company Evocatal, which specialises in the biotechnological production of fine chemicals.

The Würzburg sugar researcher Jürgen Seibel. 17.10.2012

Jürgen Seibel: The sugar exposes the tumour

Jürgen Seibel’s award for sugar research came somewhat out of the blue. He will now be using his prize money to investigate the sugar molecules on cancer cells – a possible approach for combating tumours.

Jochen Guck is a Professor of Cellular Machines at the Biotechnology Center of the Technical University of Dresden. 22.08.2012

Jochen Guck: An outsider’s path to the central nervous system

An adaptable outsider: In the course of his career, the physicist Jochen Guck has brought a number of startling discoveries to the world of biotechnology. With a Humboldt Professorship in the bag, he now conducts research at the Technical University of Dresden.

Ingrid Herr researches the therapeutic effects of secondary plant substances. 18.07.2012

Ingrid Herr: Enlightened approach to cancer prevention

Ingrid Herr is researching not only a cure for cancer, bus is also focused on prevention. She discusses her latest research findings in a recently published brochure.

Thomas Drescher, founder and board member at Jülich-based bioreactor system specialists DASGIP. 20.06.2012

Thomas Drescher: Parallel operations in the cell lab

Thomas Drescher is one of the founders of the Jülich-based company DASGIP. The bioreactor systems specialists were bought this year by Eppendorf AG – and after Europe and North America is now casting its eye on the Asian markets.

At the OncoRay Centre for Research in Oncology in Dresden, Anna Dubrovska dreams of developing a biomarker for aggressive tumour cells. 13.06.2012

Anna Dubrovska: A passion for art and cancer genes

The Ukrainian genetic scientist Anna Dubrovska knows what cancer is like from her own family experience. After research sojourns in Sweden and the USA, she is now a Junior Professor at OncoRay in Dresden, where she conducts research into biomarkers.

Christian Kurts is Director of the Institute for Experimental Immunology at University Hospital Bonn. 09.05.2012

Christian Kurts: The immunologist with a Plan B

Christian Kurts gained international recognition as a postdoc after discovering the cross-presentation mechanism of the immune system. The Bonn-based immunologist was recently awarded the Leibniz Prize.

Leibniz Prize winner Nicholas Rajewsky is setting new standards in systems biology. 10.04.2012

Nikolaus Rajewsky: making sense of the maths of biology

At the Max Delbrück Center (MDC), Nikolaus Rajewsky is an expert in the creative and productive marriage of systems biology with physics and mathematics. Rajewsky has been awarded the 2012 Leibniz Prize for his work on small RNA molecules.

  • ...